UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?

International journal of molecular sciences, 2019-04, Vol.20 (7), p.1714

2019

Volltextzugriff (PDF)

Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells

Scientific reports, 2021-09, Vol.11 (1), p.19051-19051, Article 19051

2021

Volltextzugriff (PDF)

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6635

2020

Volltextzugriff (PDF)

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Journal of translational medicine, 2022-06, Vol.20 (1), p.1-286, Article 286

2022

Volltextzugriff (PDF)

Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2028

2021

Volltextzugriff (PDF)

Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV- neu T) in Mice with Transplanted Salivary Gland Carcinoma Cells

Nutrients, 2020-05, Vol.12 (5), p.1417

2020

Volltextzugriff (PDF)

Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials

Pharmacology & therapeutics (Oxford), 2021-03, Vol.219, p.107700-107700, Article 107700

2021

Volltextzugriff (PDF)

Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition

Urologic oncology, 2019-05, Vol.37 (5), p.297.e19-297.e31

2019

Volltextzugriff (PDF)

Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells

Current opinion in pharmacology, 2021-10, Vol.60, p.315-330

2021

Volltextzugriff (PDF)

In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101

Investigational new drugs, 2020-06, Vol.38 (3), p.675-689

2020

Volltextzugriff (PDF)

Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of T H 1 and T H 2 cells

Current opinion in pharmacology, 2021-10, Vol.60, p.315

2021

Volltextzugriff (PDF)

Breast and bone: A story of hidden similarities

Chronicles of Oncology, 2018-02, Vol.1 (1)

2018

Volltextzugriff (PDF)

The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

EMBO reports, 2017-08, Vol.18 (8), p.1331-1351

2017

Volltextzugriff (PDF)

Tumor suppressor microRNAs: A novel non-coding alliance against cancer

FEBS letters, 2014-08, Vol.588 (16), p.2639-2652

2014

Volltextzugriff (PDF)

Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages

Breast cancer research : BCR, 2018-06, Vol.20 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction

Cell death & disease, 2024-02, Vol.15 (2), p.113-113, Article 113

2024

Volltextzugriff (PDF)

Regulation of Gdnf expression by retinoic acid in Sertoli cells

Molecular reproduction and development, 2020-04, Vol.87 (4), p.419-429

2020

Volltextzugriff (PDF)

The role of age in the relationship between work social characteristics and job attitudes

Journal of workplace behavioral health, 2019-04, Vol.34 (2), p.77-95

2019

Volltextzugriff (PDF)

The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer

Cell death discovery, 2024-06, Vol.10 (1), p.276-11

2024

Volltextzugriff (PDF)

Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study

British journal of haematology, 2022-10, Vol.199 (1), p.54-60

2022

Volltextzugriff (PDF)

Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages

Cells (Basel, Switzerland), 2020-02, Vol.9 (2), p.418

2020

Volltextzugriff (PDF)

On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)

Blood, 2023-11, Vol.142 (Supplement 1), p.3178-3178

2023

Volltextzugriff (PDF)

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Blood, 2023-11, Vol.142 (Supplement 1), p.1567-1567

2023

Volltextzugriff (PDF)

Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.1514-1514

2023

Volltextzugriff (PDF)

Final Analysis for the Primary End-Point of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.1536-1536

2023

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?

Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development

Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV- neu T) in Mice with Transplanted Salivary Gland Carcinoma Cells

Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials

Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition

Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells

In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101

Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of T H 1 and T H 2 cells

Breast and bone: A story of hidden similarities

The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

Tumor suppressor microRNAs: A novel non-coding alliance against cancer

Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages

ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction

Regulation of Gdnf expression by retinoic acid in Sertoli cells

The role of age in the relationship between work social characteristics and job attitudes

The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer

Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study

Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages

On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial

Final Analysis for the Primary End-Point of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Suchergebnisse filtern